Stempeutics To Introduce Stem Cell Drug In 2013
KUALA LUMPUR, May 21 (Bernama) — Stempeutics Research Malaysia Sdn Bhd, an emerging stem cell company, is to introduce a stem cell-based therapy — Ischemic Cerebral Stroke (CS) — in the global market in 2013.
[Read the full article here]Related News:
Stempeutics to launch its stem cell based new drug in India by 2012
Cipla enters stem cell segment via Rs 50-cr investment in Stempeutics
Criteria For Research On Stem Cells Soon